Neoadjuvant chemotherapy for Ewing’s sarcoma family tumors of the uterine cervix: A case report

Ewing’s sarcoma family tumors of the uterine cervix are extremely rare and, thus, an optimal treatment strategy has not yet been established. To the best of our knowledge, 28 cases were reported in the English literature between 1996 and 2020, and treatments involved surgery, neoadjuvant chemotherap...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Masahiko Mori, Kazunori Honda, Hirofumi Tsubouchi, Jun Sakata, Seiichi Kato, Shiro Suzuki
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	CD99 ESWR1 gene rearrangement Neoadjuvant chemotherapy Radical hysterectomy VDC-IE Gynecology and obstetrics RG1-991 Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/285d842f692f4db2ba20e96ddfa048e4
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:285d842f692f4db2ba20e96ddfa048e4
record_format	dspace
spelling	oai:doaj.org-article:285d842f692f4db2ba20e96ddfa048e42021-11-26T04:34:39ZNeoadjuvant chemotherapy for Ewing’s sarcoma family tumors of the uterine cervix: A case report2352-578910.1016/j.gore.2021.100895https://doaj.org/article/285d842f692f4db2ba20e96ddfa048e42021-11-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2352578921001995https://doaj.org/toc/2352-5789Ewing’s sarcoma family tumors of the uterine cervix are extremely rare and, thus, an optimal treatment strategy has not yet been established. To the best of our knowledge, 28 cases were reported in the English literature between 1996 and 2020, and treatments involved surgery, neoadjuvant chemotherapy, adjuvant chemotherapy, and radiotherapy. The vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide (VDC-IE) protocol increased the survival rate of patients with non-metastatic Ewing’s sarcoma family tumors. We herein present a case of a Ewing’s sarcoma family tumor of the cervix in a one-month postpartum woman treated with neoadjuvant chemotherapy using the VDC-IE protocol and radical hysterectomy followed by adjuvant chemotherapy, and discussed the diagnosis and treatment of this tumor through a literature review.Masahiko MoriKazunori HondaHirofumi TsubouchiJun SakataSeiichi KatoShiro SuzukiElsevierarticleCD99ESWR1 gene rearrangementNeoadjuvant chemotherapyRadical hysterectomyVDC-IEGynecology and obstetricsRG1-991Neoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENGynecologic Oncology Reports, Vol 38, Iss , Pp 100895- (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	CD99 ESWR1 gene rearrangement Neoadjuvant chemotherapy Radical hysterectomy VDC-IE Gynecology and obstetrics RG1-991 Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
spellingShingle	CD99 ESWR1 gene rearrangement Neoadjuvant chemotherapy Radical hysterectomy VDC-IE Gynecology and obstetrics RG1-991 Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Masahiko Mori Kazunori Honda Hirofumi Tsubouchi Jun Sakata Seiichi Kato Shiro Suzuki Neoadjuvant chemotherapy for Ewing’s sarcoma family tumors of the uterine cervix: A case report
description	Ewing’s sarcoma family tumors of the uterine cervix are extremely rare and, thus, an optimal treatment strategy has not yet been established. To the best of our knowledge, 28 cases were reported in the English literature between 1996 and 2020, and treatments involved surgery, neoadjuvant chemotherapy, adjuvant chemotherapy, and radiotherapy. The vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide (VDC-IE) protocol increased the survival rate of patients with non-metastatic Ewing’s sarcoma family tumors. We herein present a case of a Ewing’s sarcoma family tumor of the cervix in a one-month postpartum woman treated with neoadjuvant chemotherapy using the VDC-IE protocol and radical hysterectomy followed by adjuvant chemotherapy, and discussed the diagnosis and treatment of this tumor through a literature review.
format	article
author	Masahiko Mori Kazunori Honda Hirofumi Tsubouchi Jun Sakata Seiichi Kato Shiro Suzuki
author_facet	Masahiko Mori Kazunori Honda Hirofumi Tsubouchi Jun Sakata Seiichi Kato Shiro Suzuki
author_sort	Masahiko Mori
title	Neoadjuvant chemotherapy for Ewing’s sarcoma family tumors of the uterine cervix: A case report
title_short	Neoadjuvant chemotherapy for Ewing’s sarcoma family tumors of the uterine cervix: A case report
title_full	Neoadjuvant chemotherapy for Ewing’s sarcoma family tumors of the uterine cervix: A case report
title_fullStr	Neoadjuvant chemotherapy for Ewing’s sarcoma family tumors of the uterine cervix: A case report
title_full_unstemmed	Neoadjuvant chemotherapy for Ewing’s sarcoma family tumors of the uterine cervix: A case report
title_sort	neoadjuvant chemotherapy for ewing’s sarcoma family tumors of the uterine cervix: a case report
publisher	Elsevier
publishDate	2021
url	https://doaj.org/article/285d842f692f4db2ba20e96ddfa048e4
work_keys_str_mv	AT masahikomori neoadjuvantchemotherapyforewingssarcomafamilytumorsoftheuterinecervixacasereport AT kazunorihonda neoadjuvantchemotherapyforewingssarcomafamilytumorsoftheuterinecervixacasereport AT hirofumitsubouchi neoadjuvantchemotherapyforewingssarcomafamilytumorsoftheuterinecervixacasereport AT junsakata neoadjuvantchemotherapyforewingssarcomafamilytumorsoftheuterinecervixacasereport AT seiichikato neoadjuvantchemotherapyforewingssarcomafamilytumorsoftheuterinecervixacasereport AT shirosuzuki neoadjuvantchemotherapyforewingssarcomafamilytumorsoftheuterinecervixacasereport
_version_	1718409829826953216

Neoadjuvant chemotherapy for Ewing’s sarcoma family tumors of the uterine cervix: A case report

Ejemplares similares